IMNM
Immunome Inc
22.30$
-7.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +54.8% | +2.3% | +155.9% | -15.2% | +4.2% | +22.0% | -0.8% | +1.8% | +5.9% | -3.0% | +54.2% | – | |
| – | +166.2% | -25.1% | +49.5% | +51.6% | +11.8% | +4.3% | -6.2% | +26.2% | +17.0% | +0.8% | +10.6% | – | |
| – | – | – | -36.1% | -21.9% | +136.4% | -422.0% | – | – | -68.8% | -521.5% | – | – | |
| – | +869.4% | +520.1% | +8.3% | -34.3% | -10.7% | +166.5% | -75.3% | +23.3% | +258.3% | -24.9% | -27.5% | – | |
| – | +83,238.9% | +24.1% | +119.4% | – | -59.5% | -47.8% | -1,361.0% | – | -103.2% | +200.5% | +2,432.9% | – | |
| – | -8.8% | +295.4% | -99.7% | -56.1% | +6,485.2% | +707.7% | -100.0% | – | +853.5% | -100.0% | – | – | |
| – | -84.6% | +2,027.9% | -161.0% | – | – | – | -199.4% | – | +195.8% | -118.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.